Inventor · disambiguated record
Christopher James Lock
Also filed as: LOCK CHRISTOPHER JAMES
13 granted patents·2 pending applications·145 citations·filing 1995–2018
92Inventor score
Files withUSHER III INITIATIVE INC7GENKYOTEX SUISSE SA2USHER III INITIATIVE2ALLEN DANIEL REES1CHIROSCIENCE LTD1
Top patents by PatentIndex Score
15 records- 0191US9079909B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher SyndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 14, 2015·8 cites·14 claims
- 0291US8765762B2Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 1, 2014·11 cites·18 claims
- 0391US8399483B2Quinoxaline and quinoline derivatives as kinase inhibitorsALLEN DANIEL REES·Filed 2008·Granted Mar 19, 2013·51 cites·12 claims
- 0490US9549910B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jan 24, 2017·3 cites·2 claims
- 0590US9260381B2Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Feb 16, 2016·4 cites·2 claims
- 0690US9227976B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2013·Granted Jan 5, 2016·6 cites·38 claims
- 0787US9783545B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Oct 10, 2017·3 cites·16 claims
- 0887US9371332B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jun 21, 2016·4 cites·2 claims
- 0985US10307422B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2018·Granted Jun 4, 2019·1 cites·2 claims
- 1083US5786484ARacemization and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereofCHIROSCIENCE LTD·Filed 1995·Granted Jul 28, 1998·49 cites·18 claims
- 1182US9925187B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Mar 27, 2018·1 cites·3 claims
- 1276US10130619B2Amido thiadiazole derivatives as NADPH oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2015·Granted Nov 20, 2018·3 cites·12 claims
- 1364US8653272B2Fused pyridine derivatives as kinase inhibitorsJENKINS KERRY·Filed 2009·Granted Feb 18, 2014·1 cites·8 claims
- 1446US2019046515A1Amido thiadiazole derivatives as nadph oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2018·Application pending·0 cites
- 1545US2010035863A12 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical CompositionsUCB PHARMA SA·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher James Lock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →